Skip to main content

Marinol Side Effects

Generic name: dronabinol

Medically reviewed by Drugs.com. Last updated on Nov 26, 2023.

Note: This document contains side effect information about dronabinol. Some dosage forms listed on this page may not apply to the brand name Marinol.

Applies to dronabinol: oral capsule liquid filled, oral solution.

Serious side effects of Marinol

Along with its needed effects, dronabinol (the active ingredient contained in Marinol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking dronabinol:

Less common

Rare

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking dronabinol:

Symptoms of overdose

Other side effects of Marinol

Some side effects of dronabinol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common or rare

Rare

For Healthcare Professionals

Applies to dronabinol: oral capsule, oral solution.

Psychiatric

Very common (10% or more): Elation (up to 24%), feeling high/easy laughing (up to 24%), heightened awareness (up to 24%)

Common (1% to 10%): Abnormal thinking, euphoria, paranoid reaction

Frequency not reported: Anxiety/nervousness, confusion, depersonalization, depression, hallucinations, nightmares

Postmarketing reports: Delirium, disorientation, insomnia, panic attack[Ref]

Gastrointestinal

Common (1% to 10%): Abdominal pain, nausea, vomiting

Frequency not reported: Diarrhea, fecal incontinence

Postmarketing reports: Lip swelling, oral lesions[Ref]

Nervous system

Common (1% to 10%): Dizziness, somnolence

Frequency not reported: Amnesia, ataxia, headache, speech difficulties

Postmarketing reports: Fatigue, loss of consciousness, movement disorder, seizure/seizure-like activity, syncope[Ref]

Cardiovascular

Frequency not reported: Flushing, hypotension, palpitations, tachycardia, vasodilation/facial flush[Ref]

Other

Frequency not reported: Asthenia, chills, malaise, tinnitus

Postmarketing reports: Fall, fatigue[Ref]

Respiratory

Frequency not reported: Cough, rhinitis, sinusitis

Postmarketing reports: Throat tightness[Ref]

Ocular

Frequency not reported: Conjunctival injection, vision difficulties[Ref]

Dermatologic

Frequency not reported: Sweating

Postmarketing reports: Disseminated rash, hives, skin burning[Ref]

Hepatic

Frequency not reported: Hepatic enzyme elevation[Ref]

Musculoskeletal

Frequency not reported: Myalgia[Ref]

Metabolic

Frequency not reported: Anorexia[Ref]

References

1. Product Information. Marinol (dronabinol). Roxane Laboratories Inc. 2001;PROD.

2. Product Information. Syndros (dronabinol). Insys Therapeutics Inc. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.